Reports for GLENMARK PHARMACEUTICALS CANADA INC.
Company Name
GLENMARK PHARMACEUTICALS CANADA INC.
Totals |
||
Shortage reports |
4 |
|
Actual shortage: | 0 (0%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 4 (100%) | |
Discontinuation Reports |
0 |
|
To be discontinued: | 0 | |
Discontinued: | 0 | |
Reversed: | 0 | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS | 100MG 250MG | TABLET | Resolved | 2018-10-23 | 2019-01-12 | 65444 |
GLN-ATOVAQUONE | 750MG | SUSPENSION | Resolved | 2024-08-29 | 2024-10-17 | 236216 |
GLN-URSODIOL | 250MG | TABLET | Resolved | 2017-11-28 | 2018-01-02 | 30985 |
GLN-URSODIOL | 500MG | TABLET | Resolved | 2017-11-28 | 2018-01-02 | 30989 |
Showing 1 to 4 of 4
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0